山姆·惠特克

2023年5月30日

由山姆·惠特克和杰森,首席执行长&创始人壁画健康发表的临床试验空间变化,旧的,过时的纸质记录的方法和预付费借记卡未能满足增加的需求,数据和patient-centricity。采用混合和分散的临床试验(dct)的增加,越来越多的网站赞助商不得不外包获得他们所需要的专业知识。制药行业外包模型并不陌生。传统上,药物开发者注册提供全面服务的合同研究组织(cro)需作为一个单一的联系点。然而,随着越来越多的服务提供商,颠倒了CRO“一站式商店”临床试验技术提供商的方法是不可行的。杰森董至关重要,赞助商知道如何选择正确的技术和考虑如何优化他们的战略合作伙伴关系。技术如何提高临床试验?正确的技术可以使成规试验,扩大参与,提高满意度,和减少病人退出。所有试验——无论是传统的混合或分散——正在日益增长的支持技术支持下,从传感器和这套数据分析和远程医疗平台。效率创新包括数字协议自动化工具和参与者支付平台,降低患者的经济负担和自动化人工工作流。 How do I decide which technology provider to work with? Strategic partnerships should be just that – strategic. Vendors should not be another team to manage. Instead, they should offer expertise which extends your own knowledge base. To help ensure you build the most valuable strategic partnerships you should consider: Can the products be easily adapted to meet my needs? Is the vendor forward-thinking and future proof? Is the design user-centered? How can I deal with cross-country complexities? Fintech can be a particularly difficult area to navigate without specialist expertise due to cross-country complexities including tax regulations and the need to ensure providers are compliant and secure from a data perspective across multiple environments. Guidance on payment to participants can also vary. For example, in the UK the National Institute for Health and Care Research recommends offering payment “that is commensurate with the nature and demands of the activity and is fair when compared to other members of the research team, to acknowledge the value placed on public involvement”. Sam Whitaker Is there an easy way to connect with experts from multiple fields? While the ‘one-stop-shop’ approach does not work for clinical technology providers, some vendors have already started to partner with each other, integrating their products to provide best-in-class solutions. This allows sponsors to get the best of both worlds – a streamlined process and the benefits of strategic partnerships. For example, Mural Health’s strategic partnership with Ledger Run, an innovative technology company focused on optimizing clinical operations, provides a broader set of functions to mutual customers. Mural Health and ProofPilot have teamed up to streamline payments and provide more patient choice, while Clinical ink was able to add next-generation payment and logistics functionality to its platform thanks to its Mural Health partnership. Conclusion New technologies in clinical trials are on the rise. Sponsors need to make sure they are choosing the right technology and working with the right partners to ensure they are not left behind. Selecting clinical trial technology providers who are not just valuable strategic partners but who can also provide access to their own network of specialist experts is key to success. 60